CareTria Acquires CaryHealth to Create Leading Direct-to-Patient Pharmacy Platform

CareTria, a top therapy initiation partner backed by Frazier Healthcare Partners, has completed the acquisition of CaryHealth, an AI-powered digital pharmacy. This move has led to the formation of a comprehensive direct-to-patient pharmacy platform that integrates various key components such as product demand generation, telehealth, AI-enabled patient engagement, and high-volume dispensing automation. The integration of these elements is aimed at enhancing therapy initiation and adherence.

According to Willis Chandler, President and CEO of CareTria, the direct-to-patient platform has witnessed a 90% prescription-to-therapy initiation conversion rate. The AI-enabled digital pharmacy infrastructure from CaryHealth has significantly bolstered patient engagement and adherence, thereby strengthening the CareTria ecosystem. The combined entity is poised to deliver a more efficient, connected, and measurable patient experience across the full therapy journey, as stated by Areo Nazari, CEO of CaryHealth.

CareTria's exclusive provider network, high-speed benefit investigations, and real-time analytics drive continuous optimization across the product journey, resulting in accelerated therapy initiation and measurable impact for its pharmaceutical partners. On the other hand, CaryHealth's scalable AI solutions and integrated digital pharmacy services are designed to improve fill and adherence rates, strengthen patient relationships, and reduce administrative burden.

This strategic acquisition is expected to position the combined company as a leading pharmacy partner for biopharma, offering a unified platform that drives product awareness and demand with providers and patients, while automating patient engagement and pharmacy workflows through proprietary agentic AI. The acquisition reflects the ongoing trend of direct-to-patient access channels in the pharmacy space, highlighting the industry's focus on enhancing patient experiences and optimizing therapy initiation and adherence.

Source: PR NewsWire